Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021)
Cardiol Therapeutics' (CRDL) quarterly Depreciation & Amortization - Total came in at $27261.3 in Q2 2021, up 4.03% YoY from $26206.4 in Q2 2020, and up 4.03% on a QoQ basis from $26206.4 in Q2 2020.
Cardiol Therapeutics (CRDL) Depreciation & Amortization - Total (2020 - 2021) Analysis & Trends
Cardiol Therapeutics (CRDL) has 2 years of Depreciation & Amortization - Total data on file, last reported at $27261.3 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cardiol Therapeutics | 214.93 Mn | 196.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 27,261.30 |
| Jun 30, 2020 | 26,206.39 |